These new findings9 suggest that ferroptosis inhibitors or drugs that specifically disrupt the interactions of Mtb PtpA with Ran-GDP or PRMT6 can be explored for tuberculosis treatment. The gene discussed is PRMT6; the disease is tuberculosis.